Guardant Health GH
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Guardant Health (GH) Core Market Data and Business Metrics
Latest Closing Price
$43.49Price-Earnings Ratio
-12.22Total Outstanding Shares
123.42 Million SharesDividend
No dividendSIC Description
Services-medical LaboratoriesPrimary Exchange
NASDAQHeadquarters
3100 Hanover Street, Palo Alto, CA, 94304
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 2,588,304 Shares | 3.22 | 3/14/2025 | 8,345,886 Shares |
| 2,635,910 Shares | 3 | 2/28/2025 | 7,897,769 Shares |
| 2,159,578 Shares | 3.63 | 2/14/2025 | 7,837,356 Shares |
| 2,781,403 Shares | 2.08 | 1/31/2025 | 5,771,757 Shares |
| 2,273,210 Shares | 3.24 | 1/15/2025 | 7,364,075 Shares |
| 1,551,424 Shares | 5.02 | 12/31/2024 | 7,794,410 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $-502.16 Million |
| Net Cash Flow From Financing Activities, Continuing | $-996,000 |
| Net Cash Flow From Investing Activities, Continuing | $-261.31 Million |
| Net Cash Flow From Operating Activities, Continuing | $-239.86 Million |
| Net Cash Flow From Investing Activities | $-261.31 Million |
| Net Cash Flow From Operating Activities | $-239.86 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Basic Earnings Per Share | $-3.56 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Basic Average Shares | $122.75 Million |
| Net Income/Loss Attributable To Parent | $-436.37 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $0 |
| Net Income/Loss Available To Common Stockholders, Basic | $-436.37 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $-1.53 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss Attributable To Parent | $-437.90 Million |
| Comprehensive Income/Loss | $-437.90 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Noncurrent Assets | $430.50 Million |
| Other Current Liabilities | $187.03 Million |
| Equity Attributable To Parent | $-139.65 Million |
| Fixed Assets | $136.81 Million |
| Assets | $1.49 Billion |
| Equity | $-139.65 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||